aripiprazole has been researched along with loxapine in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (22.22) | 29.6817 |
2010's | 7 (77.78) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ernsberger, P; Hufeisen, SJ; Jayathilake, K; Kroeze, WK; Meltzer, HY; Popadak, BA; Renock, SM; Roth, BL; Steinberg, S | 1 |
Glennon, RA | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Sokolski, KN | 1 |
Chaumartin, N; Lachaux, B; Monville, M | 1 |
Arnold, LE; Han, JC; Hellings, JA | 1 |
Estrada, G; Oudovenko, N; San, L; Vieta, E | 1 |
Bukhanovskaya, O; Dobrovolskaya, N; Estrada, G; Montañés, F; Oudovenko, N; Popov, M; San, L; Vieta, E | 1 |
Garel, N; Joober, R | 1 |
3 review(s) available for aripiprazole and loxapine
Article | Year |
---|---|
Higher-end serotonin receptors: 5-HT(5), 5-HT(6), and 5-HT(7).
Topics: Animals; Humans; Ligands; Receptors, Serotonin; Serotonin Agents; Serotonin Antagonists; Serotonin Receptor Agonists | 2003 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Dopamine antagonists for treatment resistance in autism spectrum disorders: review and focus on BDNF stimulators loxapine and amitriptyline.
Topics: Adolescent; Adult; Amitriptyline; Antipsychotic Agents; Aripiprazole; Autism Spectrum Disorder; Brain-Derived Neurotrophic Factor; Child; Dopamine Antagonists; Humans; Irritable Mood; Loxapine; Risperidone | 2017 |
2 trial(s) available for aripiprazole and loxapine
Article | Year |
---|---|
Rationale and design of the PLACID study: a randomised trial comparing the efficacy and safety of inhaled loxapine versus IM aripiprazole in acutely agitated patients with schizophrenia or bipolar disorder.
Topics: Administration, Inhalation; Adolescent; Adult; Aged; Aggression; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Clinical Protocols; Humans; Injections, Intramuscular; Loxapine; Male; Middle Aged; Psychomotor Agitation; Schizophrenia; Schizophrenic Psychology; Treatment Outcome; Young Adult | 2017 |
PLACID study: A randomized trial comparing the efficacy and safety of inhaled loxapine versus intramuscular aripiprazole in acutely agitated patients with schizophrenia or bipolar disorder.
Topics: Administration, Inhalation; Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Female; Humans; Injections, Intramuscular; Loxapine; Male; Middle Aged; Psychiatric Status Rating Scales; Psychomotor Agitation; Schizophrenia; Single-Blind Method; Treatment Outcome; Young Adult | 2018 |
4 other study(ies) available for aripiprazole and loxapine
Article | Year |
---|---|
H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs.
Topics: Animals; Antipsychotic Agents; Discriminant Analysis; Drug Evaluation, Preclinical; Forecasting; Humans; Protein Binding; Receptors, Histamine H1; Statistics, Nonparametric; Weight Gain | 2003 |
Combination loxapine and aripiprazole for refractory hallucinations in schizophrenia.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Dose-Response Relationship, Drug; Drug Monitoring; Drug Resistance; Drug Therapy, Combination; Hallucinations; Humans; Loxapine; Male; Middle Aged; Piperazines; Quinolones; Schizophrenia; Serotonin 5-HT2 Receptor Antagonists; Treatment Outcome | 2011 |
[Dysphagia or dysphagias during neuroleptic medication?].
Topics: Adult; Anticonvulsants; Antipsychotic Agents; Aripiprazole; Clonazepam; Deglutition Disorders; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Substitution; Drug Therapy, Combination; Homicide; Humans; Ill-Housed Persons; Loxapine; Male; Mental Disorders; Piperazines; Quinolones; Risk Factors; Schizophrenia; Schizophrenic Psychology | 2012 |
Treatment of first-episode psychosis in patients with autism-spectrum disorder and intellectual deficiency
Topics: Adolescent; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Autism Spectrum Disorder; Delusions; Dystonia; Female; Hallucinations; Humans; Hypnotics and Sedatives; Intellectual Disability; Lorazepam; Loxapine; Olanzapine; Paranoid Disorders; Psychotic Disorders; Quetiapine Fumarate; Tourette Syndrome | 2019 |